The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ

被引:47
|
作者
Semeraro, Michaela [1 ,2 ,3 ,4 ,5 ]
Adam, Julien [6 ,7 ]
Stoll, Gautier [1 ,2 ,3 ,4 ,5 ]
Louvet, Emilie [7 ]
Chaba, Kariman [1 ,2 ,3 ,4 ,5 ]
Poirier-Colame, Vichnou [8 ,9 ,10 ]
Sauvat, Allan [1 ,2 ,3 ,4 ,5 ]
Senovilla, Laura [1 ,2 ,3 ,4 ,5 ]
Vacchelli, Erika [1 ,2 ,3 ,4 ,5 ]
Bloy, Norma [1 ,2 ,3 ,4 ,5 ,8 ]
Humeau, Juliette [1 ,2 ,3 ,4 ,5 ,8 ]
Buque, Aitziber [1 ,2 ,3 ,4 ,5 ]
Kepp, Oliver [1 ,2 ,3 ,4 ,5 ]
Zitvogel, Laurence [8 ,9 ,10 ,11 ]
Andre, Fabrice [12 ,13 ,14 ]
Mathieu, Marie-Christine [6 ]
Delaloge, Suzette [13 ,14 ]
Kroemer, Guido [1 ,2 ,3 ,4 ,5 ,15 ,16 ]
机构
[1] Gustave Roussy Canc Campus, Villejuif, France
[2] INSERM, U1138, Paris, France
[3] Ctr Rech Cordeliers, Equipe Labellisee Ligue Natl Canc 11, Paris, France
[4] Univ Paris 05, Sorbonne Paris Cite, Paris, France
[5] Univ Paris 06, Paris, France
[6] Gustave Roussy Canc Campus, Dept Med Biol & Pathol, Villejuif, France
[7] Gustave Roussy Canc Campus, INSERM, U981, Module Dev Pathol Expt, Villejuif, France
[8] Univ Paris Saclay, Fac Med, Le Kremlin Bicetre, France
[9] Ctr Clin Invest Biotherapies Canc CICBT 507, Villejuif, France
[10] Gustave Roussy Canc Campus, Dept Immunooncol, Villejuif, France
[11] INSERM, U1015, Villejuif, France
[12] INSERM, Identificat Mol Predictors & New Targets Canc Tre, Villejuif, France
[13] Gustave Roussy Canc Campus, Dept Med Oncol, Villejuif, France
[14] Gustave Roussy Canc Campus, Breast Canc Grp, Villejuif, France
[15] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France
[16] Karolinska Inst, Dept Womens & Childrens Hlth, Karolinska Univ Hosp, Stockholm, Sweden
来源
ONCOIMMUNOLOGY | 2016年 / 5卷 / 10期
基金
欧洲研究理事会;
关键词
Cytotoxic T cells; hyperploidy; immunogenic cell death; immunosuppressive regulatory T cells; intraductal carcinoma; IMMUNOGENIC CELL-DEATH; CANCER; IMMUNOSURVEILLANCE; TUMORIGENESIS; EXPRESSION; BIOMARKER;
D O I
10.1080/2162402X.2016.1218106
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a series of 248 tumor samples obtained from image-guided biopsies from patients diagnosed with ductal carcinoma in situ of the breast, we attempted to identify biomarkers that predict microinfiltration at definitive surgery or relapse during follow-up. For this, we used immunohistochemical methods, followed by automated image analyses, to measure the mean diameter of nuclei (which correlates with ploidy), the phosphorylation of eukaryotic initiation factor 2 (eIF2, which reflects endoplasmic reticulum stress) as well as the density and ratio of CD8(+) cytotoxic T lymphocytes and FOXP3(+) regulatory T cells. The median nuclear diameter of malignant cells correlated with eIF2 phosphorylation (in cancerous tissue), which in turn correlated with the density of the CD8(+) infiltrate and the CD8(+)/FOXP3 ratio (both in cancerous and the adjacent non-cancerous parenchyma). Neither microinfiltration nor lymph node involvement was associated with the probability of relapse. Both correlated positively with the CD8(+)/FOXP3 ratio in the malignant area. In contrast, relapse was associated with a paucity of the CD8(+) infiltrate as well as an unfavorable CD8(+)/FOXP3 ratio, both in malignant and non-malignant parenchyma. The combined analysis of the CD8(+)/FOXP3 ratio in cancerous and non-cancerous tissues revealed a significant impact of their interaction on the probability of relapse, but not on the presence of microinfiltration or lymph node metastasis. Altogether, these results support the idea of an immunosurveillance system that determines the risk of relapse in ductal carcinoma in situ of the breast.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Foxp3 Expression in Bovine CD8+ T Cells Is Associated with the Intensity of CD25 Expression
    Maslanka, Tomasz
    Jaroszewski, Jerzy Jan
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2013, 75 (02): : 241 - 244
  • [22] Ratio of CD8+/ FOXP3, number of FOXP3+cells and the presence of PTEN labeling in tumor cells and association with survival in triple negative breast cancer
    Tavares, Monique C.
    Lima, Geraldine E.
    Sampaio, Cristina D.
    Andrande, Victor P.
    Goncalves, Daniel G.
    Macedo, Mariana P.
    Lima, Vladmir C.
    CANCER RESEARCH, 2020, 80 (04)
  • [23] Tumour-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to neoadjuvant chemotherapy of aggressive breast cancer
    Asano, Y.
    Kashiwagi, S.
    Goto, W.
    Kurata, K.
    Noda, S.
    Takashima, T.
    Onoda, N.
    Tanaka, S.
    Ohsawa, M.
    Hirakawa, K.
    BRITISH JOURNAL OF SURGERY, 2016, 103 (07) : 845 - 854
  • [24] Presence of CD3+tumor infiltrating lymphocytes is significantly associated with good prognosis in infiltrating ductal carcinoma of breast
    Rathore, A. S.
    Kumar, S.
    Konwar, R.
    Srivastava, A. N.
    Makker, A.
    Goel, M. M.
    INDIAN JOURNAL OF CANCER, 2013, 50 (03) : 239 - 244
  • [25] Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
    Sato, E
    Olson, SH
    Ahn, J
    Bundy, B
    Nishikawa, H
    Qian, F
    Jungbluth, AA
    Frosina, D
    Gnjatic, S
    Ambrosone, C
    Kepner, J
    Odunsi, T
    Ritter, G
    Lele, S
    Chen, YT
    Ohtani, H
    Old, LJ
    Odunsi, K
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (51) : 18538 - 18543
  • [26] Evaluation of tumor infiltrating lymphocytes as a prognostic biomarker in patients with ductal carcinoma in situ of the breast
    Pasetto, Camila Vitola
    Aguiar, Fernando Nalesso
    Peixoto, Marcella Bassan
    Doria, Maira Teixeira
    Mota, Bruna Salani
    Maesaka, Jonathan Yugo
    Filassi, Jose Roberto
    Baracat, Edmund Chada
    Goncalves, Rodrigo
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 208 (01) : 9 - 18
  • [27] Higher densities of tumour-infiltrating lymphocytes and CD4+ T cells predict recurrence and progression of ductal carcinoma in situ of the breast
    Thike, Aye Aye
    Chen, Xiaoyang
    Koh, Valerie Cui Yun
    Binte Md Nasir, Nur Diyana
    Yeong, Joe P. S.
    Bay, Boon Huat
    Tan, Puay Hoon
    HISTOPATHOLOGY, 2020, 76 (06) : 852 - 864
  • [28] CD8 T lymphocytes and FOXP3 T regulatory lymphocytes in patients with high-grade squamous intraepithelial lesions
    Pukis, M.
    Mitildzans, A.
    Rezeberga, D.
    Isajevs, S.
    VIRCHOWS ARCHIV, 2019, 475 : S86 - S86
  • [29] Validation and Clinical Correlation of Triplex CD3, CD8 and FOXP3 IHC of Tumor-Infiltrating Lymphocytes in Follicular Lymphoma
    Mansfield, James
    Slater, Christian
    Oguejiofor, Kenneth
    Hall, John
    Byers, Richard
    LABORATORY INVESTIGATION, 2015, 95 : 520A - 520A
  • [30] Validation and Clinical Correlation of Triplex CD3, CD8 and FOXP3 IHC of Tumor-Infiltrating Lymphocytes in Follicular Lymphoma
    Mansfield, James
    Slater, Christian
    Oguejiofor, Kenneth
    Hall, John
    Byers, Richard
    MODERN PATHOLOGY, 2015, 28 : 520A - 520A